Develops medical devices and technologies for assisted reproductive treatment, focusing on enhancing fertility treatment options.
INVO Bioscience, Inc., a global leader in assisted reproductive technology, focuses on offering innovative solutions to enhance fertility treatments. At the forefront of its offerings is the INVOcell, a revolutionary medical device designed to facilitate fertilization and early embryo development inside the woman's body. This unique approach provides a more natural and intimate environment for conception to occur, potentially enhancing the chances of successful pregnancy.
Founded in 2007 and headquartered in Sarasota, Florida, INVO Bioscience has established itself as a pioneer in advancing fertility care. The company's commitment to innovation extends beyond technology development to encompass education and support for healthcare providers and patients navigating the complexities of infertility treatment. With its cutting-edge approach and global reach, INVO Bioscience continues to redefine possibilities in assisted reproduction, offering hope to couples striving to build families worldwide.
INVO Bioscience's mission is rooted in providing accessible and effective fertility solutions that align with the natural reproductive processes of the human body. Through ongoing research, partnerships, and community engagement, the company remains dedicated to advancing reproductive health and empowering individuals on their journey to parenthood.